Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Gilead Sciences Inc. (GILD)

-NasdaqGS
101.00 Down 0.07(0.07%) Mar 27, 4:00PM EDT
|After Hours : 100.79 Down 0.21 (0.21%) Mar 27, 7:58PM EDT
Add to Portfolio
Prev Close:101.07
Open:101.02
Bid:100.78 x 300
Ask:101.00 x 300
1y Target Est:119.08
Beta:0.83
Earnings Date:Apr 20 - Apr 24 (Est.)
Day's Range:100.90 - 102.10
52wk Range:63.50 - 116.83
Volume:8,815,858
Avg Vol (3m):13,560,800
Market Cap:150.43B
P/E (ttm):13.74
EPS (ttm):7.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.07%150.43B
GSKUp 0.77%113.11B
PFEUp 1.08%211.63B
RHHBYDown 0.23%N/A

Key Statistics

Forward P/E (1 yr):9.83
P/S (ttm):6.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :9.52
Quarterly EPS Est (Mar-15) :2.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback